Log in

NYSE:LH - Laboratory Corp. of America Stock Price, Forecast & News

$128.71
-8.34 (-6.09 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$126.36
Now: $128.71
$133.30
50-Day Range
$104.32
MA: $166.44
$195.28
52-Week Range
$98.02
Now: $128.71
$196.36
Volume1.06 million shs
Average Volume1.57 million shs
Market Capitalization$12.52 billion
P/E Ratio15.40
Dividend YieldN/A
Beta0.95
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides technology-enabled solutions, including a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with convenient and secure access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Read More
Laboratory Corp. of America logo

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$18.26 per share
Book Value$77.93 per share

Profitability

Net Income$823.80 million

Miscellaneous

Employees65,000
Market Cap$12.52 billion
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

How has Laboratory Corp. of America's stock been impacted by COVID-19 (Coronavirus)?

Laboratory Corp. of America's stock was trading at $158.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LH shares have decreased by 19.0% and is now trading at $128.71. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Laboratory Corp. of America?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 2 sell ratings, 3 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Laboratory Corp. of America.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Laboratory Corp. of America.

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) issued its quarterly earnings data on Thursday, February, 13th. The medical research company reported $2.86 EPS for the quarter, topping the Zacks' consensus estimate of $2.80 by $0.06. The medical research company earned $3 billion during the quarter, compared to the consensus estimate of $2.92 billion. Laboratory Corp. of America had a net margin of 7.13% and a return on equity of 15.37%. Laboratory Corp. of America's revenue was up 7.6% on a year-over-year basis. During the same period last year, the company posted $2.52 EPS. View Laboratory Corp. of America's earnings history.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America updated its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share (EPS) guidance of $11.75-$12.15 for the period, compared to the Thomson Reuters consensus estimate of $11.97.

What price target have analysts set for LH?

14 Wall Street analysts have issued twelve-month target prices for Laboratory Corp. of America's shares. Their forecasts range from $170.00 to $220.00. On average, they expect Laboratory Corp. of America's share price to reach $197.54 in the next twelve months. This suggests a possible upside of 53.5% from the stock's current price. View analysts' price targets for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

Media headlines about LH stock have trended positive on Saturday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Laboratory Corp. of America earned a daily sentiment score of 2.1 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutLaboratory Corp. of America.

Are investors shorting Laboratory Corp. of America?

Laboratory Corp. of America saw a decline in short interest in the month of March. As of March 13th, there was short interest totaling 1,593,400 shares, a decline of 6.8% from the February 27th total of 1,710,000 shares. Based on an average daily trading volume, of 750,400 shares, the short-interest ratio is currently 2.1 days. Approximately 1.7% of the shares of the company are sold short. View Laboratory Corp. of America's Current Options Chain.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Micron Technology (MU), NVIDIA (NVDA), Amgen (AMGN), Gilead Sciences (GILD), Allergan (AGN), Bank of America (BAC), Chipotle Mexican Grill (CMG) and Endologix (ELGX).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the following people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by a variety of institutional and retail investors. Top institutional investors include State Street Corp (4.49%), Franklin Resources Inc. (1.66%), Franklin Resources Inc. (1.66%), Boston Partners (1.61%), UBS Asset Management Americas Inc. (1.57%) and Geode Capital Management LLC (1.54%). Company insiders that own Laboratory Corp. of America stock include David P King, Der Vaart Sandra D Van, Edward T Dodson, Glenn A Eisenberg, Jean-Luc Belingard, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, Mark S Schroeder, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr. View institutional ownership trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Raymond James & Associates, Golub Group LLC, Point72 Asset Management L.P., Nuveen Asset Management LLC, Amundi Pioneer Asset Management Inc., CI Investments Inc., Janus Henderson Group PLC, and UBS Asset Management Americas Inc.. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Peter J Wilkinson, R Sanders Williams, and Robert E Mittelstaedt Jr. View insider buying and selling activity for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Madison Asset Management LLC, Renaissance Technologies LLC, Hexavest Inc., Bank of New York Mellon Corp, Great West Life Assurance Co. Can, Assenagon Asset Management S.A., and Teacher Retirement System of Texas. View insider buying and selling activity for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $128.71.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $12.52 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis. Laboratory Corp. of America employs 65,000 workers across the globe. View additional information about Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  504 (Vote Outperform)
Underperform Votes:  550 (Vote Underperform)
Total Votes:  1,054
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel